National Institute on Aging (NIA)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute on Aging (NIA) sits in the top decile of US sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count).
National Institute on Aging (NIA): 131 sponsored US clinical trials, 12 recruiting.
National Institute on Aging (NIA) sponsors 131 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 103 completed. 18 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 7 trials.
Top-decile sponsor footprint
National Institute on Aging (NIA) ranks in the top decile of sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 116 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
131 total, page 2 of 3
Memory Aid for Informed Consent in Alzheimer's Research
NCT00105612
Serum, Dietary and Supplemental Vitamin D's Association With Cognitive Decline
NCT03320109
Comparison of an Easy to Read Advance Directive Versus a Standard Advance Directive
NCT00328055
Sleepiness and the Risk of Falling
NCT00383357
Idiopathic Anemia of Aging (IAA)
NCT00104169
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00087425
Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)
NCT00246493
Age, Lifestyle, Muscle Mechanisms in Insulin Resistance
NCT00971594
Huperzine A in Alzheimer's Disease
NCT00083590
The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot
NCT00116194
Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers
NCT00233311
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00104572
Hormone Replacement Therapy (HRT) Website Tool
NCT00319072
The Effects of Metformin on Blood Vessel Structure and Function
NCT00105066
ABC Trial: Awakening and Breathing Controlled
NCT00097630
Lymphoma Follow-up
NCT00744120
Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women
NCT00113867
The TLC2 (Teaching Healthy Lifestyles to Caregivers 2)/CALM (Counseling Advice for Lifestyle Management) Study
NCT00131105
Forearm Vascular Relaxation
NCT00182923
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
NCT00089882
Early Markers of Cognitive Change and Alzheimer s Disease
NCT01867346
The Genetic Characterization of Dementia
NCT01867359
Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes
NCT01867372
Analysis of Atropine and Propranolol Induced Changes
NCT00251602
Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure
NCT00800228
Screening Protocol to Evaluate Volunteers for NIA Approved Studies
NCT02091271
GIP: Glucose-dependent Insulinotropic Peptide
NCT00239707
Studies of Heritable Disorders of Connective Tissue
NCT00270686
VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
NCT00056225
Osteoarthritis and Body Composition: Evaluation of Systematic Mediators
NCT00771082
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
NCT00053599
Dietary Energy Restriction and Metabolic Aging in Humans
NCT00183027
HORMA: Hormonal Regulators of Muscle and Metabolism in Aging
NCT00183040
MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology
NCT00239759
Effects of Dehydroepiandrosterone (DHEA) in Humans
NCT00182975
The Immune Function Intervention Trial
NCT00548990
Collection of Bone Marrow Aspirate From Volunteer Donors
NCT00183066
Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
NCT00043849
CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
NCT00099099
CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
NCT00099151
CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
NCT00099138
Race, Menopause and Metabolism After Exercise and Diet
NCT00882141
GRACE: Geriatric Resources for Assessment and Care of Elders
NCT00182962
Pioglitazone in Alzheimer Disease
NCT00982202
Testosterone Effects on Bone and Frailty
NCT00182871
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
NCT00183001
The HIP Impact Protection Program (HIP PRO)
NCT00058864
A Comparison of Weighted Vest Exercise and Strength Training
NCT00158119
Shingles: Immune Effects of Tai Chi
NCT00118885
Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans
NCT00099697
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 20 |
| Phase 3 | 14 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the National Institute on Aging (NIA) pipeline
12 recruiting of 131 indexed (9% open); 103 completed (79%).
Phase mix: 18 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Aging (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute on Aging (NIA): open-pipeline peers nationwide
Peers matched on 131 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
National Institute on Aging (NIA) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 131 trials (± recruiting share)
- Rhode Island Hospital · 130 trials · 20% recruiting
- George Washington University · 133 trials · 18% recruiting
- University of Illinois at Urbana-Champaign · 129 trials · 14% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this National Institute on Aging (NIA) page
131 registered trials is a research-attention snapshot, not an endorsement of National Institute on Aging (NIA) or any single study.
- 12 of National Institute on Aging (NIA)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition National Institute on Aging (NIA) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute on Aging (NIA) pipeline card: 131 registered trials from official public datasets.Report a data error.